Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 94029

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 14, 2024
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Golden State Medical Supply Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15

D-0349-2024
Recall number
D-0349-2024
Initiated
February 14, 2024
Classification
Class II
Status
Ongoing
Quantity
59,712 bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations
Microbial contamination reason.microbial_contamination · v1.0.0
presence of Burkholderia cepacia

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

Code information

Lot #: TX5275, Exp. Date: 10/31/2026.

Distribution pattern

Nationwide in the USA